✦ LIBER ✦

Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation

✍ Scribed by Marica Carbone, Susan Duty, Marcus Rattray

Book ID: 119895582
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 395 KB
Volume: 13
Category: Article
ISSN: 1471-2202
DOI: 10.1186/1471-2202-13-38

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroprotective properties of the natura

Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease

✍ Zbarsky, Virginia; Datla, Krishna P.; Parkar, Shabnam; Rai, Deepal K.; Aruoma, O 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 264 KB

Activation of the extracellular signal-r

Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease

✍ Niklas Lindgren; Rehana K. Leak; Kirsten M. Carlson; Amanda D. Smith; Michael J. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

## Abstract Glial cell line‐derived neurotrophic factor (GDNF) has been shown to be neuroprotective in animal models of the dopamine deficiency in Parkinson's disease. To examine the role of the extracellular signal‐regulated kinases 1 and 2 (ERK1/2) in this process, we infused a single dose of GDN

Involvement of PPAR-γ in the neuroprotec

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

✍ Pablo Garrido-Gil; Belen Joglar; Ana I Rodriguez-Perez; Maria J Guerra; Jose L L 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 931 KB